Michael Plewe

机构：Arisan Therapeutics (United States)

发表论文 28 篇 · 总被引 832 次 · h-index 13

代表论文

• A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. (1996 · Proceedings of the National Academy of Sciences · 被引 279)
• Optimization of Alkylidene Hydrazide Based Human Glucagon Receptor Antagonists. Discovery of the Highly Potent and Orally Available 3-Cyano-4-hydroxybenzoic Acid [1-(2,3,5,6-Tetramethylbenzyl)-1H-indol-4-ylmethylene]hydrazide (2002 · Journal of Medicinal Chemistry · 被引 87)
• Discovery of Selective Small Molecule Degraders of BRAF-V600E (2020 · Journal of Medicinal Chemistry · 被引 66)
• Azaindole Hydroxamic Acids are Potent HIV-1 Integrase Inhibitors (2009 · Journal of Medicinal Chemistry · 被引 53)
• New β-Alanine Derivatives Are Orally Available Glucagon Receptor Antagonists (2007 · Journal of Medicinal Chemistry · 被引 53)
• Discovery of First-In-Class Potent and Selective Tropomyosin Receptor Kinase Degraders (2020 · Journal of Medicinal Chemistry · 被引 48)